Lb Pharmaceuticals Inc · NASDAQ:LBRX
Commodore Capital LP reported a 6.80% stake in Lb Pharmaceuticals Inc (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Commodore Capital LP reported a 6.80% stake in Lb Pharmaceuticals Inc, 1,972,369 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 1,972,369
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 6.80% | 1,972,369 |
| Commodore Capital Master LP | 6.80% | 1,972,369 |
| Robert Egen Atkinson | 6.80% | 1,972,369 |
| Michael Kramarz | 6.80% | 1,972,369 |
Source
Related
- Lb Pharmaceuticals Inc
- Commodore Capital LP
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G · Commodore Capital LP · Sep 18, 2025
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026